AU4732499A - Compositions and methods for treating and preventing bone diseases using tocotrienols - Google Patents
Compositions and methods for treating and preventing bone diseases using tocotrienols Download PDFInfo
- Publication number
- AU4732499A AU4732499A AU47324/99A AU4732499A AU4732499A AU 4732499 A AU4732499 A AU 4732499A AU 47324/99 A AU47324/99 A AU 47324/99A AU 4732499 A AU4732499 A AU 4732499A AU 4732499 A AU4732499 A AU 4732499A
- Authority
- AU
- Australia
- Prior art keywords
- bone
- tocotrienol
- tocotrienols
- vitamin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004200594A AU2004200594A1 (en) | 1998-07-08 | 2004-02-16 | Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9210198P | 1998-07-08 | 1998-07-08 | |
US60092101 | 1998-07-08 | ||
PCT/US1999/015452 WO2000002553A1 (en) | 1998-07-08 | 1999-07-08 | Compositions and methods for treating and preventing bone diseases using tocotrienols |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004200594A Division AU2004200594A1 (en) | 1998-07-08 | 2004-02-16 | Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4732499A true AU4732499A (en) | 2000-02-01 |
Family
ID=22231570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47324/99A Abandoned AU4732499A (en) | 1998-07-08 | 1999-07-08 | Compositions and methods for treating and preventing bone diseases using tocotrienols |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1109548A4 (zh) |
JP (1) | JP2002520280A (zh) |
CN (1) | CN1316903A (zh) |
AU (1) | AU4732499A (zh) |
ID (1) | ID28460A (zh) |
WO (1) | WO2000002553A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US8669282B2 (en) | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
WO2002055071A1 (en) * | 2001-01-15 | 2002-07-18 | Kgk Synergize | Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols |
CA2463142A1 (en) * | 2001-10-10 | 2003-04-24 | Pharmacia Italia Spa | Methods for preventing and treating bone loss with steroid compounds |
TWI331032B (zh) * | 2002-05-01 | 2010-10-01 | Hayashibara Biochem Lab | |
FR2841472B1 (fr) * | 2002-06-28 | 2006-02-24 | Agronomique Inst Nat Rech | Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives |
FR2899106B1 (fr) * | 2002-11-19 | 2015-04-24 | Engelhard Lyon | Utilisation d'une substance pour limiter et/ou prevenir la modification d'au moins un parametre biologique modifie au cours d'une irradiation |
TW200524892A (en) * | 2003-09-24 | 2005-08-01 | Glaxo Group Ltd | Calcilytic compounds |
WO2006024096A1 (en) * | 2004-08-31 | 2006-03-09 | Chemgenex Pharmaceuticals Limited | Method for modulating osteoclastogenesis |
US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
CA2582096C (en) * | 2004-10-01 | 2014-01-07 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
ES2436181T3 (es) | 2004-12-29 | 2013-12-27 | Hill's Pet Nutrition Inc. | Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales |
WO2007009111A1 (en) | 2005-07-14 | 2007-01-18 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
US8288369B2 (en) * | 2006-06-27 | 2012-10-16 | University Of South Florida | Delta-tocotrienol treatment and prevention of pancreatic cancer |
JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
AU2016200420B2 (en) * | 2008-12-30 | 2017-03-02 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
JP5967936B2 (ja) * | 2009-03-13 | 2016-08-10 | 株式会社明治 | 骨折リスクの低減及び/又は骨折の予防のための組成物 |
NL2008294C2 (en) * | 2011-05-20 | 2013-08-19 | Friesland Brands Bv | Food composition comprising vitamin k and saturated fat. |
US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
RU2016105843A (ru) | 2013-07-22 | 2017-08-29 | Огайо Стейт Инновейшн Фаундейшн | Способы снижения частоты приливов |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0645533B2 (ja) * | 1985-02-09 | 1994-06-15 | ライオン株式会社 | 化粧料 |
US5574063A (en) * | 1989-10-12 | 1996-11-12 | Perricone; Nicholas V. | Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage |
-
1999
- 1999-07-06 ID IDW20010301A patent/ID28460A/id unknown
- 1999-07-08 CN CN99810684A patent/CN1316903A/zh active Pending
- 1999-07-08 EP EP99930883A patent/EP1109548A4/en not_active Withdrawn
- 1999-07-08 JP JP2000558813A patent/JP2002520280A/ja not_active Withdrawn
- 1999-07-08 AU AU47324/99A patent/AU4732499A/en not_active Abandoned
- 1999-07-08 WO PCT/US1999/015452 patent/WO2000002553A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1109548A4 (en) | 2001-12-12 |
WO2000002553A1 (en) | 2000-01-20 |
ID28460A (id) | 2001-05-24 |
JP2002520280A (ja) | 2002-07-09 |
EP1109548A1 (en) | 2001-06-27 |
CN1316903A (zh) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4732499A (en) | Compositions and methods for treating and preventing bone diseases using tocotrienols | |
US5464862A (en) | Method for inhibiting bone loss using centchroman derivatives | |
US5424331A (en) | Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis | |
HU224957B1 (en) | Composition for the treatment of osteoporosis and alterations due to menopause syndrome | |
US20040162247A1 (en) | Therapeutic agent or osteoporosis comprising an active ingredient of quercetin derivatives | |
US6187811B1 (en) | Methods for treating benign prostatic hyperplasia using tocotrienols | |
JP2008531602A (ja) | 抗癌特性を有する化合物 | |
MXPA04012740A (es) | Composiciones y metodos para reduccion de sintomas inflamatorios y/o biomarcadores en pacientes femeninos. | |
JP2012511547A (ja) | イソフラボン組成物 | |
EP1589964B1 (en) | Compounds having anti-proliferative properties | |
JP2001507363A (ja) | イソプレノイド類とスタチン類との組合せによる腫瘍成長抑制方法 | |
CN114225037B (zh) | 一种预防或治疗骨质疏松症的组合物及其制剂和用途 | |
WO2000064438A1 (en) | Cardiovascular and bone treatment using isoflavones | |
US20040072765A1 (en) | Cardiovascular and bone treatment using isoflavones | |
WO2005046702A1 (ja) | 歯槽骨の吸収及び歯根膜喪失を抑制する方法及びそれに用いる内服組成物 | |
US20240009177A1 (en) | Combination compositions having anti-viral activities and uses thereof | |
AU2004200594A1 (en) | Compositions and Methods for Treating and Preventing Bone Diseases Using Tocotrienols | |
EP0569415A1 (en) | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis | |
Halawa | Effect of ciprofloxacin on the articular cartilage and epiphyseal growth plate cartilage in the growing albino rats and the possible protective role of vitamin E (α–Tocopherol): a histological and morphometric study | |
KR20150108371A (ko) | 폐경기와 관련된 안면홍조의 발생을 치료/경감시키는데 사용하기 위한 n-메틸세로토닌 및 관련된 물질 | |
EP3159003A2 (en) | Composition for enhancing bone growth, preventing bone resorption disorders and for joint health | |
EP3494973B1 (en) | Compositions comprising 7-o-genistein phosphate for use in the treatment of primary osteoporosis | |
KR20220032874A (ko) | 2,4,6-트리페닐-1-헥센을 유효성분으로 포함하는 골질환 예방 또는 치료용 조성물 | |
MXPA00012944A (en) | Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome | |
CZ20004622A3 (cs) | Přípravek k prevenci a/nebo léčbě osteoporozy a změn způsobených syndromem menopauzy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |